---
$id: https://graph.org.ai/products/commodity/51281631
$type: Product
source: UNSPSC
code: "51281631"
title: "Viomycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Viomycin

**UNSPSC Code**: 51281631
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitubercular agent with the molecular formula C25H43N13O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, YVU35998K5 chemically known as glycine, 3-amino-n-((3s)-3,6-diamino-1-oxohexyl)-l-alanyl-l-seryl-l-seryl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-2-((4r,6s)-2-amino-1,4,5,6-tetrahydro-6-hydroxy-4-pyrimidinyl)-, (5->13)-lactam, (2s)- but generally known as viomycin, which bears US NIH Compound Identifier 3032902. European Medicines Agency schedules Viomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00078MIG. The term VIOMYCIN is an International Non-Proprietary Name or INN. Most nations schedule viomycin under HS 29419000 and SITC 54139. As of Q4 2014, VIOMYCIN remains the US FDA Preferred Term for this commodity. Viomycin bears US NLM identifiers UMLS ID C0042697 and NCI Concept Code C66654. SMILES: OC1N=C(NC(C2NC(=O)C(=C\NC(=O)N)\NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CC(N)CCCN)CNC2=O)CO)CO)C1)N.

